BG
AERI

BlackRock Group’s Aerie Pharmaceuticals AERI Stock Holding History

BlackRock Group’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$573K Buy
15,131
+7,050
+87% +$267K ﹤0.01% 2314
2016
Q3 		$304K Buy
8,081
+357
+5% +$7.87K ﹤0.01% 2488
2016
Q2 		$136K Sell
7,724
-120
-2% -$1.94K ﹤0.01% 2693
2016
Q1 		$95K Buy
7,844
+2,733
+53% +$43.2K ﹤0.01% 2779
2015
Q4 		$125K Buy
5,111
+2,449
+92% +$57.1K ﹤0.01% 2619
2015
Q3 		$47K Buy
+2,662
New +$48.2K ﹤0.01% 2860

Other funds holding AERI

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Group's AERI Position: Q4 2016 in Review

BlackRock Group increased its Aerie Pharmaceuticals (AERI) stake by 87% in Q4 2016, buying an estimated $267K and bringing the position to 15,131 shares worth $573K. The position accounts for ﹤0.01% of the portfolio, ranked #2314.

BlackRock Group first reported a position in AERI in Q3 2015 and has held it in 6 quarters since. 151 funds tracked by Wall St. Rank hold AERI as of Q4 2016.

  • BlackRock Group held 15,131 shares of Aerie Pharmaceuticals worth $573K as of Q4 2016.
  • BlackRock Group bought 7,050 Aerie Pharmaceuticals shares in Q4 2016, an estimated $267K.
  • Aerie Pharmaceuticals made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2314 holding.
  • BlackRock Group first reported a position in Aerie Pharmaceuticals in Q3 2015 and has held it in 6 quarters since.
  • 151 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.